Seven Eight Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Seven Eight Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-37,198	Closed	-$3.46M	–	741
2021 Q4	$3.46M	Buy	+37,198	New	+$2.45M	0.62%	33
2019 Q3	–	Sell	-27,479	Closed	-$1.61M	–	775
2019 Q2	$1.61M	Buy	+27,479	New	+$1.42M	0.09%	304
2019 Q1	–	Sell	-11,800	Closed	-$460K	–	770
2018 Q4	$460K	Buy	+11,800	New	+$463K	0.03%	433

Seven Eight Capital's ARNA Position: Q1 2022 in Review

Seven Eight Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 37,198 shares — an estimated $3.46M sold.

Seven Eight Capital first reported a position in ARNA in Q4 2018 and held it in 3 quarters. The position peaked at $3.46M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Seven Eight Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Seven Eight Capital sold 37,198 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.46M.
Seven Eight Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 3 quarters.
Seven Eight Capital's Arena Pharmaceuticals Inc position peaked at $3.46M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Seven Eight Capital's 13F filing for Q1 2022, filed 11 May 2022.